Physician profile
Kerry Eley
NPI 1780840801
$1,066.17
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $182 · 2021: $13.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $166.05 | 2019-2020 | |
| Amgen INC. | $133.39 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.02 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $68.21 | 2019-2020 | |
| Pfizer INC. | $60.69 | 2019-2020 | |
| Nalpropion Pharmaceuticals LLC | $53.97 | 2019 | |
| Glaxosmithkline, LLC. | $53.62 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.54 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $46.49 | 2019 | |
| Merck Sharp & Dohme LLC | $39.11 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $37.86 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $37.14 | 2019 | |
| Lilly USA, LLC | $36.22 | 2019-2020 | |
| Sanofi Pasteur INC. | $32.03 | 2019-2020 | |
| Amarin Pharma, INC. | $29.45 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $24.05 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $23.25 | 2019 | |
| Astellas Pharma US INC | $20.33 | 2019 | |
| Eisai INC. | $17.13 | 2019 | |
| Phadia US INC. | $14.38 | 2019 | |
| Shire North American Group INC | $13.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Eley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.